Analyst Price Target is $13.50
▲ +161.63% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Curaleaf in the last 3 months. The average price target is $13.50, with a high forecast of $32.25 and a low forecast of $5.25. The average price target represents a 161.63% upside from the last price of $5.16.
Current Consensus is
Moderate Buy
The current consensus among 7 investment analysts is to moderate buy stock in Curaleaf. This Moderate Buy consensus rating has held steady for over two years.
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through Domestic Operations and International Operations segments. The company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. In addition, it offers flowers, pre-rolls, flower pods, and dry-herb vaporizer cartridges; concentrates for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, including distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. Further, the company provides hemp-based CBD and cannabigerol products. The company was founded in 2010 and is headquartered in New York, New York.
Read More